General Announcement::CDW' subsidiary joint research on innovative LNP techonology to enter in vivo phase

Issuer & Securities

Issuer/ Manager
CDW HOLDING LIMITED
Securities
CDW HOLDING LIMITED - BMG2022E1104 - BXE
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
01-Apr-2025 17:41:30
Status
New
Announcement Sub Title
CDW' subsidiary joint research on innovative LNP techonology to enter in vivo phase
Announcement Reference
SG250401OTHRJ9B3
Submitted By (Co./ Ind. Name)
Cho Form Po
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please see attached.

Attachments

CDW MR - ABio and Neoregen Research Progress.pdf
Total size =879K